Avanos Medical (AVNS) EBT Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -2.47% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 7.77% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 0.70% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 37.81% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 4.82% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 32.11% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 61.06% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -2.57% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 14.40% |
| 10 | Avanos Medical | 1.17 Bn | 1.10 Bn | 94.20 Mn | 41.53% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 41.53% |
| Dec 31, 2025 | -56.22% |
| Sep 30, 2025 | -28.44% |
| Jun 30, 2025 | -128.86% |
| Mar 31, 2025 | 9.94% |
| Dec 31, 2024 | -163.06% |
| Sep 30, 2024 | 52.10% |
| Jun 30, 2024 | 41.39% |
| Mar 31, 2024 | 28.17% |
| Dec 31, 2023 | 29.64% |
| Sep 30, 2023 | 14.77% |
| Jun 30, 2023 | 4.74% |
| Mar 31, 2023 | -44.76% |
| Dec 31, 2022 | 61.34% |
| Sep 30, 2022 | 35.68% |
| Jun 30, 2022 | 38.77% |
| Mar 31, 2022 | 31.65% |
| Dec 31, 2021 | -34.95% |
| Sep 30, 2021 | -18.57% |
| Jun 30, 2021 | -106.60% |
| Mar 31, 2021 | 1.37% |
| Dec 31, 2020 | -69.65% |
| Sep 30, 2020 | 38.21% |
| Jun 30, 2020 | 32.75% |
| Mar 31, 2020 | 50.54% |
| Dec 31, 2019 | 67.34% |
| Sep 30, 2019 | -53.24% |
| Jun 30, 2019 | -47.39% |
| Mar 31, 2019 | -44.60% |
| Dec 31, 2018 | -26.76% |
| Sep 30, 2018 | 26.22% |
| Jun 30, 2018 | -56.43% |
| Mar 31, 2018 | -34.86% |
| Dec 31, 2017 | -36.86% |
| Sep 30, 2017 | -48.45% |
| Jun 30, 2017 | -75.32% |
| Mar 31, 2017 | -33.80% |
| Dec 31, 2016 | -73.13% |
| Sep 30, 2016 | -43.66% |